Quick Answer
Evolent Health, Inc. reported Stockholders Equity of $415.19 million for fiscal year 2025.
Evolent Health, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $415.19M | -58.5% |
| 2024 | $1.00B | -6.2% |
| 2023 | $1.07B | +24.2% |
| 2022 | $859.42M | +23.9% |
| 2021 | $693.63M | +11.9% |
| 2020 | $619.60M | -33.3% |
| 2019 | $929.05M | -18.8% |
| 2018 | $1.14B | +13.2% |
| 2017 | $1.01B | +43.9% |
| 2016 | $702.53M | +8.2% |
| 2015 | $649.34M | +31469.1% |
| 2014 | -$2.07M | -115.6% |
| 2013 | $13.26M | +155.0% |
| 2012 | $5.20M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $842.23M | -18.9% | -6.0% |
| June 30, 2025 | $896.00M | -15.0% | -4.2% |
| March 31, 2025 | $935.52M | -10.7% | -6.6% |
| December 31, 2024 | $1.00B | -6.2% | -3.6% |
| September 30, 2024 | $1.04B | -5.2% | -1.4% |
| June 30, 2024 | $1.05B | -3.6% | +0.6% |
| March 31, 2024 | $1.05B | -6.6% | -1.9% |
| December 31, 2023 | $1.07B | +24.2% | -2.6% |
- Evolent Health, Inc. showed a decrease of -58.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, Evolent Health, Inc.’s stockholders equity has grown by 7883.0% (from $5.20 million to $415.19 million).
- The most recent figure is from Evolent Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: